Invention Grant
- Patent Title: Triazine derivatives
-
Application No.: US14829842Application Date: 2015-08-19
-
Publication No.: US09296761B2Publication Date: 2016-03-29
- Inventor: Thomas Allen Chappie , Christopher John Helal , Bethany Lyn Kormos , Jamison Bryce Tuttle , Patrick Robert Verhoest
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent J. Michael Dixon
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D471/04 ; C07D498/04 ; C07D513/04 ; C07D519/00 ; A61K31/53 ; A61K31/4353
Abstract:
The present invention is directed to a new class of triazine derivatives as described by formula I below in which A, X, R1, R2, R3, and R4 are as defined herein and to the use of the compounds as PDE10 inhibitors.
Public/Granted literature
- US20150353579A1 Triazine Derivatives Public/Granted day:2015-12-10
Information query
